Invention Grant
US08258122B2 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
有权
3 - ([1,2,4]三唑并[4,3-a]吡啶-7-基)苯甲酰胺衍生物
- Patent Title: 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
- Patent Title (中): 3 - ([1,2,4]三唑并[4,3-a]吡啶-7-基)苯甲酰胺衍生物
-
Application No.: US12529490Application Date: 2008-02-29
-
Publication No.: US08258122B2Publication Date: 2012-09-04
- Inventor: Bernat Vidal Juan , Paul Robert Eastwood , Jacob Gonzalez Rodriguez , Cristina Esteve Trias
- Applicant: Bernat Vidal Juan , Paul Robert Eastwood , Jacob Gonzalez Rodriguez , Cristina Esteve Trias
- Applicant Address: ES Barcelona
- Assignee: Almirall, S.A.
- Current Assignee: Almirall, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: ES200700565 20070302
- International Application: PCT/EP2008/001616 WO 20080229
- International Announcement: WO2008/107125 WO 20080912
- Main IPC: A61K31/56
- IPC: A61K31/56 ; A61K31/437 ; A61K31/5377 ; A61K31/506 ; C07D471/04 ; C07D413/14 ; C07D401/14 ; A61P37/02 ; A61P19/02 ; A61P25/00 ; A61P9/00 ; A61P1/00
![3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives](/abs-image/US/2012/09/04/US08258122B2/abs.jpg.150x150.jpg)
Abstract:
New inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) are disclosed herein, as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy.
Public/Granted literature
- US20100120731A1 3-([1,2,4]TRIAZOLO [4,3-A]PYRIDIN-7-YL)BENZAMIDE DERIVATIVES Public/Granted day:2010-05-13
Information query